🇺🇸 FDA
Pipeline program

Kuvan®

EMR 700773-002

Approved small_molecule completed

Quick answer

Kuvan® for Phenylketonuria is a Approved program (small_molecule) at BIOMARIN PHARMACEUTICAL INC with 2 ClinicalTrials.gov record(s).

Program details

Company
BIOMARIN PHARMACEUTICAL INC
Indication
Phenylketonuria
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials